Search results for "ffpe challenges"

How can a proteomics platform that can measure over 7,000 protein biomarkers from one sample be used to assess an individual’s overall health, monitor disease progression, and inform healthcare decisions?

We hear how scientists’ feedback helped shape an automated cell counter with a difference

Dr. Clifton Ray discusses the potential of Nanotrap particles to advance extracellular vesicle research, and how his team is using them to break down barriers in isolation, screening, and disease diagnostics

Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality

Find out how advanced cell counting technology is helping scientists improve the efficiency of bioethanol production

Quality control and antibody validation expert Julie Wickenden shares how she works to ensure full protein knock-out in Abcam’s cell line portfolio

Sebastian Weber discusses the hot topic of digitized laboratories and why you should consider integrating software into your workflows

Watch this on-demand webinar to learn how LC and LC-MS technologies are being applied to the analysis of rAAV viral vectors

The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable

Connect your lab to ensure data integrity

Find out how CRISPR/Cas9 KO cell line technology can speed up target identification, validation, and pathway discovery with these insider insights

Future-proofing the Biopharmaceutical QC Laboratory: Using the ACQUITY UPLC H-Class Bio System for HPLC Peptide Mapping

Kits for increasing immunofluorescence sensitivity using HRP-catalyzed tyramide signal amplification; with your choice of next-generation fluorescent CF® dyes or biotin.

SureSelect Cancer CGP assay offers comprehensive genomic profiling for solid tumors. This pan-cancer NGS panel enables detection of somatic variants, including single nucleotide variants (SNVs), copy number variants (CNVs), insertions/deletions (indels), translocations (TLs), gene fusions, and the immuno-oncology biomarkers TMB (tumor mutational burden) and MSI (microsatellite instability).